Colvard-Kandavel Eye Center

06/27/2025

Our team's dedication shines through in every patient review!
We believe shared experiences inspire growth and improvement.

Have you had a life-changing encounter with us? Share your story and help spark a wave of comments below!

06/13/2025

Have you been inspired by a remarkable experience with us? We'd be honored to hear your empowering story! Share your thoughts in the comments below.

06/06/2025

At Colvard-Kandavel Eye Center, we're dedicated to providing the highest quality care and ensuring each patient's experience is exceptional. This Yelp review truly reflects the commitment and passion of our entire team.

We'd love to hear your story! Share your thoughts in the comments below or reach out to us directly.

05/13/2025

Dear Patients,

We hope this letter finds you well. At the Colvard-Kandavel Eye Center, we are always looking for ways to bring the latest advancements in eye care to our patients. We’re pleased to share information about an exciting new treatment option for patients with mild to moderate open-angle glaucoma: the iDose® implant.

What is iDose?
iDose is a tiny, innovative implant that delivers long-term medication (travoprost) directly inside the eye to help lower intraocular pressure. The medication is delivered consistently for up to 36 months. The iDose is designed to reduce or even eliminate the need for daily glaucoma eye drops, making glaucoma management simpler and more consistent.

Why consider iDose?
• Continuous drug delivery: iDose releases travoprost, a common glaucoma drop, steadily over time, helping to maintain stable eye pressure.

• Convenience: Reduces or eliminates the need for daily eye drops.

• Proven safety: In clinical trials, iDose has demonstrated a strong safety profile and has been well tolerated by patients.

• Versatile treatment: It can be implanted as a standalone procedure or combined with cataract surgery, making it a great option for patients undergoing cataract removal, and it can be combined with the lens of your choice. iDose can also be combined with other Microinvasive Glaucoma Surgeries (MIGS) such as iStent infinite to further enhance the glaucoma treatment.

• Effective treatment: Dr. Kandavel and Dr. Dredge were honored to participate in the FDA studies which led to the approval of iDose. As a result they are amongst the most experienced surgeons in the nation with this new technology. In those trials iDose was found to reduce pressure by up to 10 mmHg and up to 70% were medication free at 2 years.

If you have been managing open-angle glaucoma and are looking for a low-maintenance, effective treatment option, iDose may be a great fit for you. We would be happy to discuss whether iDose is right for your individual needs. If you are interested in learning more, please don’t hesitate to call us at 818-906-2929.

05/10/2025

Our team's dedication shines through in every patient review!

We believe shared experiences inspire growth and improvement.

Have you had a life-changing encounter with us? Share your story and help spark a wave of comments below!

05/03/2025

A shining testament to the unwavering dedication and passion of our entire team!

Have you been inspired by a remarkable experience with us? We'd be honored to hear your empowering story! Share your thoughts in the comments below.

04/26/2025

Another Yelp review truly reflects the commitment and passion of our entire team.

Have you had a positive experience with us? We'd love to hear your story! Share your thoughts in the comments below or reach out to us directly.

04/19/2025

At Colvard-Kandavel Eye Center, we're dedicated to providing the highest quality care and ensuring each patient's experience is exceptional. This Yelp review truly reflects the commitment and passion of our entire team.

Have you had a positive experience with us? We'd love to hear your story! Share your thoughts in the comments below or reach out to us directly.

04/18/2025

Dr. Michael Colvard's Memorial

We are honored to share this memorial video tribute dedicated to our beloved Dr. Michael Colvard, who passed away in September 2024. We reflect on Dr Colvard’s extraordinary kindness and humanity, groundbreaking contributions to ophthalmology, his profound generosity, and unwavering commitment to philanthropic missions in Namibia.

His innovative work has transformed eye care and inspired countless professionals. His contributions elevated both patient care and medical research. Thank you for joining us in celebrating the cherished memories of a true visionary and dear friend.

Sincerely,
Rom Kandavel
Justin Dredge
Steve Yoon
Steve Rabinowitz
Robert Medina

We are honored to share this memorial video tribute dedicated to our beloved Dr. Michael Colvard, who passed away in September 2024. We reflect on Dr. Colvar...

12/13/2024

“I am thrilled to be joining the Colvard-Kandavel Eye Center and am eager to serve the community with comprehensive ophthalmology care. With over three decades of experience in the field, I have held roles including Medical Director at North Valley Eye and California Eye Specialist in Mission Hills. I am also affiliated with Providence Holy Cross Medical Center, where I have served on the executive committee at the Surgery Center, and I continue to serve as an Assistant Clinical Professor of Ophthalmology at UCLA’s Jules Stein Eye Institute. My practice is rooted in providing advanced, patient-centered eye care, and I am deeply committed to improving access to care through community initiatives such as Eye Care America. My expertise spans a wide range of ophthalmologic conditions, and I take pride in delivering personalized care to help patients achieve optimal eye health.”
-Dr. Smyth-Medina, MD

04/05/2024

The Colvard-Kandavel Eye Center is proud of Dr. Justin Dredge's ongoing commitment to advancing the field of glaucoma treatment and care. Dr. Dredge has recently embarked on a research study aimed at comparing the two most popular types of glaucoma trabecular bypass stents: the Hydrus stent and the iStent inject. This research aims to further understand the effectiveness of these advanced technologies in managing glaucoma and preserving your vision.

The Hydrus stent and the iStent inject are microinvasive glaucoma surgery devices (MIGS). They are designed to improve the drainage of fluid from the eye by stenting open the trabecular meshwork, thus reducing intraocular pressure and slowing down the progression of glaucoma. Both stents have a proven track record of efficacy and safety and are commonly performed during a routine cataract surgery operation.
Dr. Dredge is dedicated to ensuring patients at Colvard-Kandavel Eye Center receive the highest standard of care. Participation in the study is voluntary, and the decision to include a patient in the research study will be made with careful consideration of their individual medical needs.

We appreciate your trust in Dr. Justin Dredge and his commitment to advancing the field of glaucoma research. Together, we aim to provide you with the best possible care and contribute to the ongoing progress in treating glaucoma.

04/03/2024

We are excited to share our most recent publication in EyeWorld Magazine, authored by our own Dr. Kandavel. This is one of the most widely distributed ophthalmic publications in the country. Dr. Kandavel, alongside other leaders in the field of cataract surgery, was interviewed by the editors of this prestigious magazine. In the attached article, Dr. Kandavel shares his recommendations for patient selection for cataract surgery. We hope that this information can be helpful if you are considering a consultation for cataract surgery.

The doctors at the Colvard-Kandavel Eye Center continue to innovate and contribute to clinical research and publications to further the understanding of ophthalmology and ophthalmic surgery. This allows us to provide the very latest technologies to our patients. We will continue to strive to provide you with the most advanced and compassionate care.